AI and Neurogenomics: Innovations in Precision Medicine for Brain Disorders
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: 20 September 2025 | Viewed by 698
Special Issue Editors
Interests: genetic counseling; neurogenetics; pharmacogenetics; rare disorders; genetic diagnosis
Special Issues, Collections and Topics in MDPI journals
2. Forensic Genetics Laboratory, Department of Biomedicine and Prevention, Tor Vergata University, 00133 Rome, Italy
Interests: forensic genetics; genetic counselling; human identification; neurogenetics; prenatal and postnatal genetic diagnosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The advent of artificial intelligence (AI) in genomic medicine has allowed the development of innovative protocols for the evaluation of patients, diagnosis, and management. In genomic medicine, the integration of these new technologies lays the basis for the automated evaluation of big genomic data. In fact, machine learning algorithms can help in decoding genomic variants associated with several brain diseases. Neurogenomics has demonstrated that the integration of genomic evaluation supports the application of precision medicine to patients affected by both multifactorial and mendelian neurological disorders, such as Alzheimer's, Parkinson's, schizophrenia, and neuromuscular disorders. By integrating multi-omics data—genomics, transcriptomics, and epigenomics—AI models have demonstrated interesting abilities. The application of AI models, under strict human control, supports the identification of disease-associated biomarkers, helps in the prediction of patient-specific responses to treatments, and accelerates drug discovery.
In this Special Issue, we welcome reviews and original articles covering many aspects of artificial intelligence applications in neurogenomics. These include, but are not limited to, new diagnostic, therapeutic, and neuroimaging protocols; functional and molecular evaluation of neurogenetic disorders; translation of research data into medical protocols; new management perspectives; and multi-omic analysis of disease trajectory. This Special Issue of Genes will emphasize AI’s potential to bridge the gap between genetic research and clinical practice, offering a roadmap for future innovations in brain health. By leveraging AI’s computational power, precision medicine can move closer to individualized, data-driven solutions for treating neurological disorders, improving patient outcomes, and reshaping the future of neuroscience and healthcare.
Dr. Stefania Zampatti
Dr. Emiliano Giardina
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurogenetics
- genomics
- artificial intelligence
- brain disorders
- neurodegenerative disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
